Get free blog

Health Highlights: Oct. 19, 2007

erectile dysfunction drugs

Here are some of the latest health and medical news developments,
compiled by editors of HealthDay:

ADVERTISEMENT

Impotence Drugs to Carry Hearing Loss
Warnings

New warnings about the potential risk of sudden hearing loss will be
added to the labels of Viagra and other drugs to treat erectile
dysfunction, the U.S. Food and Drug Generic erectile dysfunction drugs
says.

While it's not clear whether the drugs actually do cause hearing loss,
the FDA said that since 1996 there have been 29 reports of hearing
problems among users of these kinds of drugs, the Associated Press
reported.

The new warnings will be carried by the impotence drugs Viagra, Cialis
and Levitra, as well as the pulmonary hypertension drug Revatio, which
contains the same ingredient as Viagra.

In the 29 reports noted by the FDA, hearing loss occurred within hours
to two days after patients took one of the drugs, said FDA ear-and-nose
specialist Dr. Robert Boucher.

“We don't know enough to say that it's ironclad caused by the drugs,
but we see enough to say we can't ignore it either,” he told the
AP.

People who take the drugs and experience hearing loss or ringing in the
ears should stop the medications and contact their doctor, the FDA
said.

—–

San Francisco May Consider Tadalafil alternative

Site

In what may turn out to be the first step toward opening a
safe-injection site, San Francisco officials co-sponsored a symposium
Thursday on a facility in Vancouver, British Columbia, the only such
program in North America, the Associated Press reported.

At the Vancouver site, about 700 intravenous drug users shoot up
heroin, cocaine and other narcotics under the supervision of nurses. San
Francisco health officials may consider a safe-injection site as a way to
reduce the city's high rate of fatal drug overdoses.

“Having the conversation today will help us figure out whether this is
a way to reduce the harms and improve the health of our community,” said
Grant Colfax, director of HIV prevention for the San Francisco Department
of Health, the AP reported.

However, a federal official said the city's consideration of a
safe-injection site was “disconcerting” and “poor public policy.”

“The underlying philosophy is, 'We accept drug addiction, we accept the
state of affairs as acceptable. This is a form of giving up,” Bertha
Madras, deputy director of demand reduction for the White House Office of
National Drug Control Policy, told the AP.

There are 65 safe-injection sites in 27 cities in eight countries. So
far, San Francisco is the only U.S. city to consider creating a legal
safe-injection site, said Hilary McQuie, Western director for the
nonprofit Harm Reduction Coalition, which promotes alternative drug
treatment methods.

—–

CDC Redesigns Spanish Web Site

The U.S. Centers for Disease Control and Prevention says it's
redesigned its Spanish Web site, CDC en Espanol, with a new look and features meant to
make it more usable and functional.

The redesigned site has a more useful and powerful search engine, quick
access to the 20 most-requested topics of information, a user-friendly A-Z
index, and other features that will make it easier for people to find the
health and science information they seek, the CDC said.

The site, which provides information in Spanish on health issues of
special interest to Hispanic communities, has more than six million
visitors a year and its weekly distribution list includes almost 6,000
members in more than 40 countries.

—–

Sunlight May Decrease Risk of Advanced Breast
Cancer

Exposure to sunlight — which boosts levels of vitamin D in the body –
may reduce the risk of advanced breast cancer, according to a U.S. study
published online this week in the American Journal of
Epidemiology
.

The study of 1,788 breast cancer patients and 2,129 women who didn't
have the disease found that women with high sun exposure had half the risk
of developing advanced breast cancer than women with low sun exposure.
However, this effect was noted only in women with naturally light skin
color.

“We believe that sunlight helps to reduce women's risk of breast cancer
because the body manufactures the active form of vitamin D from exposure
to sunlight,” lead researcher Esther John, of the Northern California
Cancer Center, said in a statement. “It is possible that these effects
were observed only among ed pills
women because sun exposure produces
less vitamin D among women with naturally darker pigmentation.”

John and her colleagues emphasized that women should not sunbathe in an
attempt to reduce their breast cancer risk.

“If future studies continue to show reductions in breast cancer risk
associated with sun exposure, increasing vitamin D intake from diet and
supplements may be the safest solution to achieve adequate levels of
vitamin D,” co-researcher Gary Schwartz, of the Manufacturer tablet tadalafil
Cancer
Center at Wake Forest University School of Medicine, said in a
statement.

—–

Bad Habits Increase Osteoporosis
Risk

Smoking, excess alcohol consumption, being underweight, lack of
exercise, and poor nutrition are factors that could increase the risk of
osteoporosis later in life, says an International Osteoporosis Foundation
(IOF) report released to mark World Osteoporosis Day on Oct. 20.

Osteoporosis risk factors fall into two main categories, modifiable and
fixed. People can't control fixed risk factors — such as age, gender, and
family history — but they can do things that may lessen their
effects.

Following a bone-healthy lifestyle — including eating a nutritious
diet, getting regular exercise, and avoiding smoking and excess alcohol
consumption — can help build strong bones and prevent fractures, the IOF
said.

By 2050, it's estimated that the incidence of hip fracture (a major
consequence of osteoporosis) will increase by 310 percent in men and 240
percent in women, according to IOF Chief Executive Officer Daniel
Navid.

Report author and IOF board member Professor Cyrus Cooper said if
“people recognize osteoporosis risk factors when they are young and take
appropriate action, it can have enormous positive impact on their bone
health in later years.”

—–

Millions of American Teens Smoke, Drink, Use
Drugs Each Day: Report

On an average day in 2006, 1.2 million American teens smoked
cigarettes, 631,000 drank, 586,000 used marijuana, almost 50,000 used
inhalants, 27,000 used hallucinogens, 13,000 used cocaine, and 3,800 used
heroin, according to a government report released Thursday.

It also found that on an average day, almost 8,000 adolescents ages 12
to 17 drank alcohol for the first time, about 4,300 used an illicit drug
for the first time, about 4,000 smoked cigarettes for the first time,
almost 3,600 used marijuana for the first time, and about 2,500 abused
pain reliever for the first time.

The report, by the U.S. Substance Abuse and Mental Health Services
Administration (SAMHSA), is based on national surveys conducted and
analyzed by the agency's Office of Applied Studies.

“While other studies have shown that significant progress has been made
in lowering the levels of substance abuse among young people in the last
few years, this report shows many young people are still engaging in risky
behavior,” SAMHSA Administrator Terry Cline said in a prepared
statement.

“By breaking the data down and analyzing on a day-to-day basis, we gain
fresh perspective on how deeply substance abuse pervades the lives of many
young people and their families,” Cline said.

buy cialis

Lilly gets FDA nod on new osteoporosis drug use

erectile dysfunction drugs

CHICAGO (Reuters) -
Eli Lilly & Co (LLY.N) said on Friday
that it had won approval to market its blockbuster osteoporosis
drug to tadalafil india
women who are at high risk for invasive
breast cancer.

ADVERTISEMENT

The company also said U.S. health regulators had extended
the use of the drug, known as Evista, to help reduce the risk
of the aggressive form of breast cancer in post-menopausal
women who have the bone-thinning disease.

However, the drug will also contain a stronger warning of
side effects that can include death by stroke.

Evista, known generically as raloxifene, is already
approved for the prevention and treatment of osteoporosis, or
bone thinning, in post-menopausal women.

Lilly said Evista, like the hormone estrogen, helps to
fight osteoporosis. But Evista also blocks estrogen in breast
tissue, the drug maker said.

Sales of Evista, a selective estrogen receptor modulator,
topped $1 billion in 2006.

SERMs are drugs used to treat osteoporosis that also appear
to prevent breast cancer by reducing estrogen in breast tissue.
Estrogen in breast tissue can drive some types of breast
cancer.

“This data's been unfolding for the last few years, so it's
not as if physicians are not aware of this, but now Lilly will
be able to market it,” said Deutsche Bank analyst Barbara Ryan.

In 2007, Evista sales were flat with the prior year, she
noted. “Our view is that this (approval) may begin to deliver
some growth of maybe 10 to 20 percent,” she said.

That would equate to roughly $100 million to $200 million
in tadalafil alternative
revenues annually. “But it doesn't dramatically
move the needle at Lilly,” Ryan said. “So it's not momentous,
but we'll watch the scripts like everyone else, and maybe we'll
be surprised.”

Lilly, whose other products include antidepressant Prozac
and erectile dysfunction drug Cialis, reported second-quarter
revenue of $4.63 billion.

Earlier this year, Lilly updated the label for Evista to
include safety information from a clinical trial that evaluated
post-menopausal women, some of whom were suffering from
coronary artery disease and some who were at increased risk for
coronary disease.

The trial found no increase in the incidence of stroke but
an increase in the incidence of death because of stroke.

Since the new label for Evista will include new uses and an
expanded patient population, Lilly has worked with the FDA to
revise the package insert. The insert will now emphasize that
women with an active or past history of venous thromboembolism
tadalafil online
deadly blood clots — should not take Evista and
that women at risk for stroke should receive the drug only
after careful evaluation.

A company trattamento cronico tadalafil
said the so-called black-box warning
did not preclude the company from conducting direct-to-consumer
advertising.

The company presented studies of 37,000 women that compared
Evista with a placebo or tamoxifen, which has been used about
25 years to treat patients with advanced breast cancer.

Competing osteoporosis drugs include Merck & Co Inc's
(MRK.N) Fosamax, and Roche Holding AG's (ROG.VX) and
Erectile dysfunction help
Plc's (GSK.L) Boniva.

Shares of Eli Lilly were down 33 cents at $56.85 in morning
New York Stock Exchange trade. Their price has ranged from
$51.13 to $60.63 during the past 52 weeks.

(Reporting by Debra Sherman)

Read another articles about generic cialis 20mg x 10 pills.

Lilly beats forecasts, raises ‘07 view

erectile dysfunction drugs

NEW YORK (Reuters) -
Eli Lilly and Co. (LLY.N) on Tuesday
posted cialis wonder buy genuine tadalafil
quarterly earnings and raised its
2007 forecast, helped by surging sales of its buy cialis generic online

drugs, including depression treatment Cymbalta.

Lilly posted strong revenue gains from Cymbalta and Zyprexa
for schizophrenia, which rose 67 percent and 9 percent,
respectively, and helped the company beat revenue expectations
by about $250 million.

“Together these two products accounted for almost two
thirds of the revenue beat,” JPMorgan analyst Roberto Cuca
wrote in a research note. “This should boost sentiment among
those investors who had been concerned about the health of
Lilly's (central nervous system) franchise.”

The second-quarter results also signaled Lilly's
acquisition of Icos in January is paying off, accounting for
about a third of the 20 percent jump in quarterly sales to
$4.63 billion. Through that deal, Lilly gained full ownership
of the widely used Cialis impotence pill, which posted a 26
percent rise in sales to $293 billion.

Lilly shares rose 2 percent in opening trade.

Excluding charges related to tadalafil
of Hypnion Inc.
and Ivy Animal Health in the period, Lilly earned 90 cents per
share, which was 8 cents better than analysts had expected,
according to Reuters Estimates.

On a net basis after those charges, the Indianapolis-based
drug maker earned $664 million, or 61 cents per share, from
$822 million, or 76 cents per share, a year earlier.

Lilly forecast 2007 earnings per share, excluding special
items, of $3.40 to $3.50 per share, up from its previous
forecast of $3.29 to $3.39 per share. It expects sales to grow
in the “mid-teens” percentage range.

Cymbalta's revenue rise to $520 million in the second
quarter was helped by its new use against tadalafil tablet
anxiety
disorder approved by U.S. regulators in February.

Meanwhile Zyprexa, the company's biggest product, rebounded
with a 9 percent rise to $1.21 billion after earlier sales
declines prompted by concerns over its tendency to cause weight
gains.

Lilly said higher overseas sales of Zyprexa, along with
higher U.S. prices, outstripped lower U.S. demand for the
medicine. The company projected “modest” worldwide sales growth
of Zyprexa for the full year.

Gemzar, used to treat lung and pancreatic cancer, grew 15
percent to $396 million, while lung cancer treatment Alimta
jumped 35 percent to $207 million.

Sales of Strattera, used to treat attention deficit
hyperactivity disorder, slipped one percent to $142 million,
amid concerns that such drugs pose heart risks and cause
psychiatric problems, such as hallucinations.

Eli Lilly shares rose $1.12 to $58.29 in opening trade on
the New York Stock Exchange. They are up 12 percent in 2007,
outpacing a 2 percent rise for the American Stock Exchange
Pharmaceutical index. (.DRG)

(Reporting by Ransdell Pierson and Lewis Krauskopf)

Tadalafil 20 mg, and more another.

Eli Lilly beats 2Q forecasts

erectile dysfunction drugs

INDIANAPOLIS - Core medicines Zyprexa and Cymbalta helped Eli Lilly and Co. beat Wall Street’s tadalafil online
sildenafil citrate tablet, although profits fell 19 percent at the tadalafil 20mg
company because of acquisition costs.

ADVERTISEMENT

The drug maker’s earnings fell to $663.6 million, or 61 cents per share, from $822 million, or 76 cents per share, in the previous year. The results were dragged down 29 cents by the acquisitions of two companies, Hypnion Inc. and Ivy Animal Health Inc.

Excluding those charges, adjusted earnings totaled $978.7 million, or 90 cents per share. Analysts had expected 82 cents per share on that basis, according to Thomson Financial.

Lilly’s revenue topped forecasts as well, rising 20 percent to $4.63 billion. Analysts were expecting sales of $4.39 billion.

The jump was triggered in part by sales of the depression treatment Cymbalta, which surged 67 percent to $519.5 million. Lilly’s top-selling drug, the anti-psychotic Zyprexa, saw sales increase 9 percent to $1.2 billion.

“Sales were strong, so in terms of quality I think (the quarter) was very good,” said analyst Joseph Tooley of A.G. Edwards & Sons Inc.

Lilly raised its 2007 sales and profit guidance and is now forecasting full-year adjusted earnings per share in the range of $3.40 to $3.50, or $2.75 to $2.85 per share on a reported basis. On average, analysts were seeking profit of $3.39 per share.

Lilly shares closed unchanged at $57.17.

Revenue from another top Lilly product, the erectile buy cialis tadalafil
drug Cialis, increased 26 percent to $293 million. Lilly now gets all the sales from that drug; previously it split the revenue with ICOS Corp., which it acquired this year.

The osteoporosis drug Evista saw slow growth, with sales rising 1 percent to $278 million. But it received a boost Tuesday when a U.S. Food and Drug Administration committee recommended its use to reduce the risk of invasive breast cancer for some women.

Cymbalta, Cialis and several other drugs launched this decade now comprise 32 percent of Lilly’s revenue total, reducing Lilly’s reliance on Zyprexa, which goes off patent in 2011.

“These products that they have launched are growing meaningfully … and they’re relatively early in their product life cycle,” Tooley said.

Company leaders also touted their product pipeline during a Tuesday conference call with analysts. President and Chief Operating Officer John Lechleiter said Lilly has had eight drugs enter early-stage clinical trial testing this year and expects to hit its goal of 15.

However, Miller Tabak and Co. analyst Les Funtleyder noted that drugs in early stages of development are too shaky to count on for future revenue.

“I still have some uncertainty about where the next couple of years worth of growth is going to come from,” he said. “I wish they had more in their late stage pipeline than they do.”

generic cialis 20mg x 120 pills, and more another.

Product contains tadalafil

erectile dysfunction drugs

Confidence Inc. is recalling about 1,500 boxes of Long Weekend dietary purchase viagra
because representatives from the

Food and Drug Woman take viagra

Food and Drug Administration found the product contains undeclared tadalafil, which makes the product an unapproved drug. Tadalafil is a drug used to treat erectile dysfunction. Tadalafil can interact with nitrates found in some prescription drugs and could lower blood pressure to sildenafil citrate tablet levels. People with diabetes, high blood pressure, high pills
or heart disease often take nitrates, does viagra woman
to the FDA. No illnesses have been reported.

The product comes in three-capsule boxes. It was sold nationwide and in Puerto Rico, Canada, the United Kingdom, Russia and China. Details: by phone at 516-767-1870.

generic cialis 20mg x 30 pills

Three Words to Avoid in Emails

erectile dysfunction drugs

MailChimp.com identifies three innocent words not to use in an email subject line.

ADVERTISEMENT

Atlanta, GA (PRWEB) October 2, 2007 — MailChimp conducted a study of its customers' email campaigns and found that some of the most harmless words can spell disaster when included in email subject lines. Because of bulging inboxes and an endless torrent of spam, the study found that readers treat new emails as guilty until proven innocent. The study concluded that if an email marketer wants their emails to get read, both by friends and business contacts, there are a few words that a marketer would be well served to avoid.

Based on the results of this study, MailChimp has created a list of the top 3 words to avoid in a subject line based on analysis of over 200 million emails:

Help
Never put the word “help” in the subject title. It may be like a crime in progress where passer-bys keep on walking, or maybe most readers have just reached their respective capacity to “help”, but most readers do not respond to this word. The reluctance to open “help” messages may also stem from well-known scams asking for tadalafil 20mg
. The most common source for these scams is Nigeria. You can read more about email scams in the New York Times.

% off
While it may be counterintuitive, the stronger the commercial pitch in the subject line, the less likely it's going to be read. Consumers have had to become savvy in navigating their email inbox - as soon as an email smells like a sleazy offer, it's zapped with the delete button.

Reminder
Always avoid using the word “reminder” in the subject line. If a marketer needs to send out a reminder, MailChimp recommends avoiding the word “reminder” and, instead, communicate in the subject line that there is useful information inside that the reader is going to want. Analogous to “reminder” is repeating the same subject line for a particular event and sending out several emails in advance. The first email may get read, but after that it's splitsville.

The three innocuous words above are joining the rank of other citrate generic sildenafil viagra spammy words like: Free, Sex, Cialis, etc. Not only will an email not get read if the subject line or body is peppered with these spam words, odds are it won't even get to the reader. And getting an HTML email to the targeted inbox has become even more of a challenge, thanks to firewalls and spam filters. The net result is an obliterated email that never gets to the intended recipient.

By avoiding the three words mentioned above, email marketers should be more successful in getting their intended audience to open their emails.

About this study

MailChimp analyzed over 200 million emails as part of this study looking at email open rates and subject lines. To read more about this study, as well as MailChimp's secret formula for writing the best email subject line, visit the MailChimp.com Resource Center.

About MailChimp

MailChimp provides tadalafil for sale
email marketing services worldwide to over 10,000 small businesses, design agencies, non-profits, buy tadalafil
, and e-Commerce sites. With MailChimp you can create cause of impotence in man, eye-catching HTML emails in minutes. At MailChimp it's “Your Logo, Not Ours”. We do not add any marketing messages or logos to your email. Try out MailChimp's free trial to see how the Chimp can work for you.

###

MailChimp
Neil Bainton
404-551-2987
E-mail Information

Trackback URL: http://prweb.com/pingpr.php/UGlnZy1Mb3ZlLUluc2UtTWFnbi1UaGlyLVplcm8=

See related site about buy cialis.

Online Pharmacy Cracks Down on Fraud and Underage Consumers

erectile dysfunction drugs

Fraud and underage consumers have always posed a problem when seeking online medications. It seems anyone can order medications online without verifying their age and their identity. Accessrx, an online pharmacy, makes it mandatory for each customer to be verified and validated before their order is processed.

ADVERTISEMENT

Tempe, AZ (PRWEB) October 3, 2007 — Accessrx.com, the web's leading online pharmacy since 1999, has just introduced Secure Medical's innovative technology to process their orders. Once an order is placed online, the real work is done behind the scenes to ensure safety, security, and tadalafil and generic
.

For customers who are shopping online for their medications, these innovations also mean more than reduced fraud, protection against identity theft and lower priced prescriptions. Accessrx.com provides assurance that only licensed American doctors and licensed American pharmacies are able to ship FDA approved medications. As a consumer, it is important to look for an online pharmacy that does not sell any controlled and/or generic pills. One example of a violation would be the sale of generic Viagra. The generic form of Viagra is in violation of U.S. patent law, including the Federal Food, Drug, and Cosmetic Act. The crackdown of online pharmacies that are illegally selling and importing non-FDA approved Viagra is something that Pfizer, the manufacturer of Viagra, monitors with great concern. Learn more about accessrx's erectile dysfunction product guarantee.

Each order placed by either phone, or web will receive a trattamento cronico tadalafil
cross-check which verifies the customer's date of birth, address, zip code, and other relevant information.

“A cross-check is a real time generic cialis 10mg
process that can quickly verify a customer's age ,” says accessrx.com chief operating officer, Joel Korsunsky. “If Secure Medical concludes that the age does not match, we then request the customer to fax in their ID, or the order itself will be cancelled.”

Secure Medical is the online processing company that utilizes a real time verification service on e-script websites.

“So far in 2007, we have been able to identify and reduce incidents of fraud by 50% using this resource,” said C.O.O Joel Korsunsky.

Typically, a person using a stolen credit card gets caught in one of the many verification steps employed by Secure Medical. Another important advantage for the consumer is what your on line seller is doing to protect your personal information including credit card data. Secure Medical is PCI certified for maximum assurance in credit card storage information. Are you aware that over 155 Million records have been acquisto tadalafil
in the United States, since February 2005?

In a recent survey conducted by accessrx.com which asked, “What convinced you to order with us (2,838 answers)?” The #1 reason for ordering was convenience, followed by security.

“When I want to buy Viagra online, I look for a website that has a telephone number, is located in the USA, ships FDA approved medications, and has a secure ordering process,” said Jim K., customer of accessrx.com.

These results were followed by other preferences such as privacy, product, price, and service. Customers appreciate the convenience and privacy of ordering genuine prescription medication, as an buying cialis generic
to going to their local pharmacy, which in the end, are factors higher rated than the concern about price itself.

About accessrx.com:
Accessrx is an online pharmacy where consumers can purchase; Viagra, cialis, levitra, chantix, propecia, and other leading lifestyle medications. They ship your prescription medication by Federal Express to ensure their customer's package is delivered accurately and on time. Their professional customer care support team is available to handle calls 6:00 a.m. 7:30 p.m. M-SA.

Press Contact:
Rich Bernstein
Marketing Director
480-505-5725
www.accessrx.com

###

Secure Medical
Rich Bernstein
480-505-5725
E-mail Information

Trackback URL: http://prweb.com/pingpr.php/U3F1YS1TcXVhLUVtcHQtVGhpci1UaGlyLVplcm8=

How do yo think, is it true about generic cialis?

News - Viagra rival approved in US

erectile dysfunction drugs

The United States Government has approved the sale of a new drug expected to raise the stakes in the male impotence market.

Levitra, the first market rival to the hugely andrologia tadalafil
Viagra, is being manufactured by the German firm, Bayer AG, and marketed by the British firm GlaxoSmithKline (GSK) as an alternative oral therapy for erectile dysfunction.

Since its appearance in 1998, sales of Pfizer’s Viagra have risen to nearly $2bn a year.

Both pills work in the same manner and doctors warn that both can have serious side effects, especially for men with heart problems.

A third n tadalafil
pill, Cialis, is expected to reach the US market later this year.

The US Food and Drug Administration (FDA) approved Levitra, an orange pill compared to Viagra’s blue, based on studies showing that men were on average five times more likely to achieve an erection suitable for intercourse when taking the pill compared with those given a dummy medicine.

Researchers reported that studies of several thousand men showed that Viagra helped more than 70% improve their
erections.

As well as the warnings to men with heart tadalafil generic
, the FDA said Levitra was not for patients with who had suffered a recent heart attack or stroke who have very low blood pressure or uncontrolled high blood pressure.

For otherwise healthy men, Levitra’s main side effects
were headache, flushing and a stuffy nose and sometimes dizziness.

Lawson Macartney, head of strategic management of Generic cialis 10mg
cialis tadalafil generic rezeptfrei
, metabolic and urology drugs, said: “We know, from considerable market research, that the
market is ready for new options”.

GSK expects Levitra to be available in September.

How do yo think, is it true about generic cialis 20mg x 60 pills?

News - Fake obesity drugs are discovered

erectile dysfunction drugs


A batch of a counterfeit obesity drug has been recalled by the UK’s medicines watchdog.

The Medicines and Healthcare Manufacturer tablet tadalafil
Agency (MHRA) said it was asking for the return of batch number 65542 of counterfeit Reductil 15mg.

The drugs were discovered within the UK supply chain, the second such discovery in recent days.

Last week, counterfeit Cialis capsules, used to treat erectile dysfunction, were also discovered.

Prior to that, the last discovery of counterfeit drugs in the UK supply chain was in 1994.

However, the leading drug company Pfizer recently warned of the dangers of fake drugs entering the legitimate system.

It said this could happen because of “parallel packaging” - where drugs made in one country are repackaged for another.

Concerns

The MHRA said that initial tests on the fake Reductil tablets did not indicate that it posed an immediate risk to patients.

It advised anyone who had the product with the batch number 65542 anywhere on the pack should return it to where it was obtained.

Professor Kent Woods, chief executive of the MHRA, said: “Although the quality of counterfeit medicines cannot be guaranteed, there is no indication from testing
of the counterfeit product that it poses an immediate risk to patients.

“If patients have any concerns about possible side effects they should discuss them with their doctor.”

The MHRA said that no batches manufactured and distributed by Abbott Laboratories Ltd, the licence holder of the authentic Reductil tablets, were affected by this recall and there was no concern with the Abbott product.

David Pruce, Director of Practice and Quality Improvement at the Royal Pharmaceutical Society of Great Britain, said: “We know that counterfeit medicines are a tadalafil for sale
problem but prior to the identification of these two products, counterfeiting in the UK had been a rare occurrence.

“The society has been working with the MHRA through our team of Inspectors and we ask cialis generic online purchasing tadalafil
to 20 tadalafil with the MHRA’s investigation and to be alert for counterfeit medicines.”

He added: “Patients are advised to contact their doctor or pharmacist in the event of any concern.”

Read another articles about buy Tadalafil.

News - Fake drugs find leads to recall

erectile dysfunction drugs

The UK’s medicines watchdog is recalling a batch of a tadalafil soft
drug after fake tablets were discovered.


The Medicines and Healthcare products Regulatory Agency (MHRA), in conjunction with Pfizer, is recalling packs of Lipitor 20mg tablets.


Only those bearing the batch number 004405K1 are affected.


The MHRA said patients were not at any immediate risk from the fake drugs, which should be returned to chemists.


Patients will then be given new supplies of the bulk citrate powder tadalafil
drug.


Fake tablets can be identified because they do not come in sealed packets in which the genuine drug is provided.


Tip-off


Pfizer said hundreds of batch numbers were released each year, and the recall only applied to this one.


There were around three million prescriptions for Lipitor issued in 2004.


Seventy-three packets of counterfeit Lipitor have so far been discovered after a tip-off from customs officers in Rotterdam, Holland.


It is the third time since the beginning of 2004 that fake drugs have entered the pharmaceutical supply chain in the UK.


Last year, counterfeit batches of Cialis, used to treat impotence, and Reductil, used to treat obesity, were discovered.


Nimo Ahmed, head of intelligence at the MHRA, said: “It is the vigilance of the MHRA that has led us to identify the counterfeit Lipitor and recall this product.


“Although the quality of counterfeit medicines cannot be guaranteed, our testing of the counterfeit product indicates that there is no immediate risk to patients. If patients have any concerns about possible tadalafil western open
they should discuss them with their doctor.”


Pfizer called for more effort to be made by authorities in the UK and Europe to ensure the safety of medicines


Barcode


Kate Lloyd, medical director of Pfizer UK, said: “Patient safety is our top concern and we are seriously alarmed at the discovery of counterfeit medicine in the UK.


“Patient safety is at risk if counterfeit products can easily be introduced into the supply chain through n tadalafil
trade, as patients will not gain the benefits their doctor intended when selecting their medicine.”


She said measures including outlawing the repackaging of original manufacturers’ medicines, supporting the introduction of tamper-resistant medicine packaging, and introducing a standardised European barcode for medicines could all help to protect medicine supplies.


However, Richard Freudenberg, of the British Association of European Pharmaceutical Distributors, told the BBC News website it was disingenuous of Pfizer to associate tadalafil loc mx
with parallel distribution.


He said overlabelling or repackaging undertaken by parallel distributors was carried out under strict guidelines.


“The impression left by Pfizer UK’s medical director is that parallel distribution of medicines in Europe is thoroughly flawed and a soft target for counterfeiters to introduce their illegal and dangerous products into the market.


“In fact, there has never been a single confirmed case in the UK of a counterfeit medicine reaching a patient as parallel distribution, ever.


Mr Freudenberg said the current fakes were a replica of the pack distributed by Pfizer in the UK.


“Counterfeit medicines in Europe remain remarkably rare.


“Parallel distributors, however, are concerned about the future possibility of their entering the supply chain, and would be pleased to discuss with manufacturers available means to prevent this happening.”


Professor Peter Weissberg, Medical Director of the British Heart Foundation (BHF), said: “This is not an issue that should cause any worry for patients taking Lipitor.


“We would urge any patients who have this particular batch number on their packet to follow the MHRA’s advice and return the product to where they obtained it and seek a replacement of the genuine drug.”

Read another articles about buy generic cialis.